Evidence map›Paper›PMID 36450434›Full record

ArticleBMJ open2022

Comorbidities in patients with migraine in Japan: a cross-sectional study using data from National Health and Wellness Survey.

Shoji Kikui, Yirong Chen, Ken Ikeda, Miki Hasebe, Keiko Asao, Takao Takeshima

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Review
  5. The Gut-brain Connection and Episodic Migraine: an Update.Current pain and headache reports · 2023
    Review
  6. Diagnostics (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Shoji KikuiDepartment of Neurology & Headache Center, Tominaga Hospital, Osaka, Japan.
Yirong ChenCerner Enviza, Singapore.
Ken IkedaAmgen K.K, Tokyo, Japan.
Miki HasebeAmgen K.K, Tokyo, Japan.
Keiko AsaoAmgen K.K, Tokyo, Japan.
Takao TakeshimaDepartment of Neurology & Headache Center, Tominaga Hospital, Osaka, Japan ttakeshi@tominaga.or.jp.ORCID 0000-0003-2678-6956
Amgen (United States) · USTominaga hospital · JPCerner (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aims to examine the association between migraine and various psychiatric and somatic comorbidities in Japan.

designCross-sectional study using existing data of the 2017 Japan National Health and Wellness Survey (NHWS).

settingNationally representative sample of persons (in terms of age and gender) living in the general community aged 18 years or older in Japan.

participantsOut of a sample of 30 001 NHWS respondents, 378 respondents were identified as migraine patients and 25 209 were identified as non-migraine patients. After propensity score (PS) matching (1:4), 1512 matched non-migraine respondents were identified. PRIMARY AND SECONDARY OUTCOME MEASURES: Prevalence and PS-matched prevalence ORs (PORs) were assessed for each psychiatric and somatic comorbidity among migraine patients and matched non-migraine respondents (including migraine patients with less than 15 monthly headache days (MHDs) and migraine patients with more than 15 MHDs).

resultsMigraine patients were predominately female and had significantly higher prevalence than matched non-migraine respondents to have psychiatric and somatic comorbidities. Psychiatric comorbidities with >5% prevalence among migraine patients included depression, post-traumatic stress disorder and anxiety disorders, while gastrointestinal disorders were the most prevalent somatic comorbidity category. Other somatic comorbidities included allergies, insomnia, premenstrual syndrome and anaemia. Migraine patients with more than 15 MHDs tended to have higher point estimates for POR.

conclusionPsychiatric and somatic conditions were more prevalent in migraine patients than matched non-migraine respondents, some being novel associations not previously reported in Japan. This study provided insights on comorbidities, which could complicate care, clinical practice and outcomes among migraine patients.

Indexed as

Migraine DisordersComorbidityCross-Sectional StudiesFemaleHeadacheHealth SurveysHumansJapanMigrainePUBLIC HEALTHQuality in health care

Identifiers

PMID36450434
PMCPMC9716839
OpenAlexW4310477885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.